|54.50|| +0.44 / +0.81%|
Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company that manufactures and markets pharmaceutical products. It operates through three business segments which include Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products. The Pharmaceutical Services & Active Ingredients segment consists of its Active Pharmaceutical Ingredients business and Custom Pharmaceutical Services business. It also includes contract research services and the manufacture and sale of active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Global Generics segment consists of finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. It includes the operations of the company's biologics business. The Proprietary Products segment involves the discovery of new chemical entities and differentiated formulations for subsequent commercialization and out-licensing. The company's differentiated formulations portfolio consists of new, synergistic combinations and technologies that improve safety and/or efficacy by modifying pharmacokinetics of existing medicines. It also involves the company's specialty pharmaceuticals business, which conducts sales and marketing operations for in-licensed and co-developed dermatology products. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
|Gunupati Venkateswara Prasad||Co-Chairman, Chief Executive Officer & MD|
|Saumen Chakraborty||President, CFO & Global Head-IT|
|Abhijit Mukherjee||Chief Operating Officer|
|M. V. Ramana||EVP, Head-Emerging Markets & Global Generics|
|Umang Vohra||EVP & Head-North America Generics Business|